Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smadja

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
The EMBO Journal|March 28, 1998
Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawalF Simonin, O Valverde, C Smadja, et al.
Annales Pharmaceutiques Francaises|February 1, 2021
[Quality guidelines for radiopharmacy: Development of a risk-assessment tool]C Hosselet, D Peyronnet, M Lamballais, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 1998
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptorH W Matthes, C Smadja, O Valverde, et al.
Cell Proliferation|January 10, 2008
Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver diseaseN Levicar, M Pai, N A Habib, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
The EMBO Journal|March 28, 1998
Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawalF Simonin, O Valverde, C Smadja, et al.
Annales Pharmaceutiques Francaises|February 1, 2021
[Quality guidelines for radiopharmacy: Development of a risk-assessment tool]C Hosselet, D Peyronnet, M Lamballais, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 1998
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptorH W Matthes, C Smadja, O Valverde, et al.
Cell Proliferation|January 10, 2008
Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver diseaseN Levicar, M Pai, N A Habib, et al.
Pageof 12